Evaluation of HER2 status in endometrial carcinoma using endometrial, gastric, and breast cancer criteria: focus on HER2-low
Journal of Gynecologic Oncology · 2026 · 37 (5)
DOI: 10.3802/jgo.2026.37.e86 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2026. Verfasst von Heesoo Yoon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Seoul National University Bundang Hospital, Seongnam, Korea. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Erb-b2 Receptor Tyrosine Kinases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Seoul National University College of Medicine Research foundation.
Abstract (Originalsprache)
OBJECTIVE: To evaluate human epidermal growth factor receptor 2 (HER2) status in endometrial carcinoma (EC) using 3 different criteria, assess its association with clinicopathological and molecular characteristics, and investigate intertumoral heterogeneity and prognostic significance, focusing on HER2-low. METHODS: HER2 immunohistochemistry was performed on whole-slide sections from 365 EC and interpreted using EC, gastric cancer (GC), and breast cancer (BC) criteria. Silver in situ hybridization was performed for 2+/3+ cases. Intertumoral heterogeneity was assessed in 30 matched primary and recurrent/metastatic tumors. RESULTS: Among 365 ECs, HER2-positive tumors (2.0%) were strongly associated with serous histology, high-grade, and the p53-abnormal (p53-abn) subgroup (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Seoul National University Bundang Hospital, Seongnam, Korea.
- Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.
- Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea.
- Department of Pathology, Seoul National University College of Medicine, Seoul, Korea. hyojinkim7137@gmail.com.
ORCID-Profile: Heesoo Yoon, Yeon Bi Han, Dong Hoon Suh, Kidong Kim, Jae Hong No, Yong Beom Kim, Hyojin Kim
Förderung
- Seoul National University College of Medicine Research foundation
Zitieren
APA
Yoon, H., Han, Y. B., Suh, D. H., Kim, K., No, J. H., Kim, Y. B., & Kim, H. (2026). Evaluation of HER2 status in endometrial carcinoma using endometrial, gastric, and breast cancer criteria: focus on HER2-low. Journal of Gynecologic Oncology, 37(5). https://doi.org/10.3802/jgo.2026.37.e86
Vancouver
Yoon H, Han YB, Suh DH, Kim K, No JH, Kim YB, et al. Evaluation of HER2 status in endometrial carcinoma using endometrial, gastric, and breast cancer criteria: focus on HER2-low. Journal of Gynecologic Oncology. 2026;37(5). doi:10.3802/jgo.2026.37.e86
BibTeX
@article{Yoon2026,
author = {Yoon, Heesoo and Han, Yeon Bi and Suh, Dong Hoon and Kim, Kidong and No, Jae Hong and Kim, Yong Beom and Kim, Hyojin},
title = {Evaluation of HER2 status in endometrial carcinoma using endometrial, gastric, and breast cancer criteria: focus on HER2-low},
journal = {Journal of Gynecologic Oncology},
year = {2026},
volume = {37},
number = {5},
doi = {10.3802/jgo.2026.37.e86}
}
EUVIMED